Jennifer Marlo, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1939 Indianapolis Blvd, Whiting, IN 46394 Phone: 219-659-3541 |
Mrs. Olga Grbich, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1939 Indianapolis Blvd, Pharmacy Dept., Whiting, IN 46394 Phone: 219-659-3541 Fax: 219-473-9124 |
Richard F Austin, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1939 Indianapolis Blvd, Whiting, IN 46394 Phone: 219-659-3541 |
Katarzyna Tarkowska-szudy Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1301 119th St, Whiting, IN 46394 Phone: 219-659-0299 Fax: 219-659-7660 |
Susan P Danielson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1939 Indianapolis Blvd, Whiting, IN 46394 Phone: 219-659-3541 Fax: 219-473-9124 |
Thomas E Cutka Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1939 Indianapolis Blvd, Whiting, IN 46394 Phone: 219-659-3541 Fax: 219-473-9124 |
Marcia Perrin, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1301 119th St, Whiting, IN 46394 Phone: 219-659-0299 |
News Archive
Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced the initiation of a Phase 3 clinical trial, known as PERSIST-2, which will evaluate pacritinib, a novel, investigational JAK2/FLT3 inhibitor, in patients with myelofibrosis whose platelet counts are less than or equal to 100,000 per microliter (uL).
Retinoblastoma protein RB1, which is named after a form of pediatric tumor of the eye, is among the most common genetically regulated cellular proteins to malfunction in human cancer. RB1 was also the first tumor suppressor gene to be identified and its modes of inactivation in retinoblastoma tumors provided the basis for the ground-breaking two-hit hypothesis by the geneticist Alfred G. Knudson in the 70s, according to which cancer is due to the accumulation of multiple 'hits' or mutations in certain genes.
China has confirmed its seventh human infection and third human death from bird flu which follows two fatalities from the virus in Anhui province in eastern China.
Researchers at Northwestern Memorial Hospital, Northwestern University Feinberg School of Medicine and The Rehabilitation Institute of Chicago (RIC) recently enrolled their first subject in a national clinical research trial of a human embryonic stem cell-based therapy for participants with a subacute thoracic spinal cord injury.
› Verified 1 days ago